SG/PUT/ABBOTT LABORATORIES/70/0.1/20.09.24 Stock

Warrant

DE000SW3X7Q1

Market Closed - Deutsche Boerse AG 03:43:35 2024-06-14 pm EDT
0.001 EUR 0.00% Intraday chart for SG/PUT/ABBOTT LABORATORIES/70/0.1/20.09.24
6 months-98.25%
Current year-97.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 0.001 0.00%
24-06-13 0.001 0.00%
24-06-12 0.001 0.00%
24-06-11 0.001 0.00%
24-06-10 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 03:43 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW3X7Q
ISINDE000SW3X7Q1
Date issued 2023-09-25
Strike 70 $
Maturity 2024-09-20 (96 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.001
Spread 0.019
Spread %95.00%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus